Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study
Therapeutic Delivery · 2024
DOI: 10.4155/tde-2023-0107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Delivery, 2024. Verfasst von Mohammad Soroosh Hajizade und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, PO:7146864685. Hauptthemen laut MEDLINE: Streptokinase, Thrombosis, Molecular Dynamics Simulation, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shiraz University of Medical Sciences.
Abstract (Originalsprache)
Aim
Streptokinase has poor selectivity and provokes the immune response. In this study, we used in silico studies to design a fusion protein to achieve targeted delivery to the thrombus. Materials & methods: Streptokinase was analyzed computationally for mapping. The fusion protein modeling and quality assessment were carried out on several servers. The enzymatic activity and the stability of the fusion protein and its complex with plasminogen were assessed through molecular docking analysis and molecular dynamics simulation respectively.
Results
Physicochemical properties analysis, protein quality assessments, protein-protein docking and molecular dynamics simulations predicted that the designed fusion protein is functionally active.
Conclusion
Our results showed that this fusion protein might be a prospective candidate as a novel thrombolytic agent with better selectivity. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, PO:7146864685.
- School of Advanced Medical Sciences & Technologies, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
- Arnold & Marie Schwartz College of Pharmacy & Health Sciences, Long Island University, Brooklyn, NY 11201, USA.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
- Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
ORCID-Profile: Mohammad Soroosh Hajizade
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Hajizade, M. S., Raee, M. J., Faraji, S. N., Farvadi, F., Kabiri, M., Eskandari, S., & Tamaddon, A. M. (2024). Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. Therapeutic Delivery. https://doi.org/10.4155/tde-2023-0107
Vancouver
Hajizade MS, Raee MJ, Faraji SN, Farvadi F, Kabiri M, Eskandari S, et al. Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. Therapeutic Delivery. 2024. doi:10.4155/tde-2023-0107
BibTeX
@article{Hajizade2024,
author = {Hajizade, Mohammad Soroosh and Raee, Mohammad Javad and Faraji, Seyed Nooreddin and Farvadi, Fakhrossadat and Kabiri, Maryam and Eskandari, Sedigheh and Tamaddon, Ali Mohammad},
title = {Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study},
journal = {Therapeutic Delivery},
year = {2024},
doi = {10.4155/tde-2023-0107}
}
EUVIMED